APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mosapride

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Mosapride Market Outlook and Growth Opportunities 2026

19 December 2025194 pages

Choose your research edition.

Industry ResearchMosapride Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Mosapride Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Mosapride Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mosapride Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Mosapride Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Mosapride market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Mosapride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Mosapride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mosapride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Mosapride market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Mosapride market include DAIICHI SANKYO, Dainippon Pharmaceutical Co., Ltd., Nihon Generic, NIPPON CHEMIPHAR CO., LTD., SAWAI PHARMACEUTICAL CO., LTD., Sumitomo Dainippon Pharma, Konghong Pharmaceutical, HAOSON PHARMA and Lunan Pharmaceutical Group, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Mosapride market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mosapride and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mosapride revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Mosapride market.

Mosapride Segment by Company

DAIICHI SANKYO

Dainippon Pharmaceutical Co., Ltd.

Nihon Generic

NIPPON CHEMIPHAR CO., LTD.

SAWAI PHARMACEUTICAL CO., LTD.

Sumitomo Dainippon Pharma

Konghong Pharmaceutical

HAOSON PHARMA

Lunan Pharmaceutical Group

Mosapride Segment by Type

Tablet

Capsule

Others

Mosapride Segment by Application

Gastritis

Dyspepsia

Others

Mosapride Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Mosapride status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Mosapride key companies, revenue, market share, and recent developments.

3. To split the Mosapride breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Mosapride market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Mosapride significant trends, drivers, influence factors in global and regions.

6. To analyze Mosapride competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mosapride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mosapride and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mosapride.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mosapride industry.

Chapter 3: Detailed analysis of Mosapride company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Mosapride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Mosapride in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Mosapride Industry Trends Table 2. Mosapride Industry Drivers Table 3. Mosapride Industry Opportunities and Challenges Table 4. Mosapride Industry Restraints Table 5. Global Mosapride Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Mosapride Revenue Share by Company (2021-2026) Table 7. Global Mosapride Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Mosapride Key Company Manufacturing Base & Headquarters Table 9. Global Mosapride Company, Product Type & Application Table 10. Global Mosapride Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Mosapride by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Tablet Table 15. Significant Companies of Capsule Table 16. Significant Companies of Others Table 17. Global Mosapride Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Mosapride Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Mosapride Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Mosapride Sales Value Share by Type (2021-2026) Table 21. Global Mosapride Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Gastritis Table 23. Significant Companies of Dyspepsia Table 24. Significant Companies of Others Table 25. Global Mosapride Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Mosapride Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Mosapride Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Mosapride Sales Value Share by Application (2021-2026) Table 29. Global Mosapride Sales Value Share by Application (2027-2032) Table 30. Global Mosapride Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Mosapride Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Mosapride Sales Value Share by Region (2021-2026) Table 33. Global Mosapride Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Mosapride Sales Value Share by Region (2027-2032) Table 35. Global Mosapride Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Mosapride Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Mosapride Sales Value Market Share by Country (2021-2026) Table 38. Global Mosapride Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Mosapride Sales Value Market Share by Country (2027-2032) Table 40. DAIICHI SANKYO Company Information Table 41. DAIICHI SANKYO Business Overview Table 42. DAIICHI SANKYO Mosapride Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. DAIICHI SANKYO Mosapride Product Portfolio Table 44. DAIICHI SANKYO Recent Development Table 45. Dainippon Pharmaceutical Co., Ltd. Company Information Table 46. Dainippon Pharmaceutical Co., Ltd. Business Overview Table 47. Dainippon Pharmaceutical Co., Ltd. Mosapride Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Dainippon Pharmaceutical Co., Ltd. Mosapride Product Portfolio Table 49. Dainippon Pharmaceutical Co., Ltd. Recent Development Table 50. Nihon Generic Company Information Table 51. Nihon Generic Business Overview Table 52. Nihon Generic Mosapride Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Nihon Generic Mosapride Product Portfolio Table 54. Nihon Generic Recent Development Table 55. NIPPON CHEMIPHAR CO., LTD. Company Information Table 56. NIPPON CHEMIPHAR CO., LTD. Business Overview Table 57. NIPPON CHEMIPHAR CO., LTD. Mosapride Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. NIPPON CHEMIPHAR CO., LTD. Mosapride Product Portfolio Table 59. NIPPON CHEMIPHAR CO., LTD. Recent Development Table 60. SAWAI PHARMACEUTICAL CO., LTD. Company Information Table 61. SAWAI PHARMACEUTICAL CO., LTD. Business Overview Table 62. SAWAI PHARMACEUTICAL CO., LTD. Mosapride Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. SAWAI PHARMACEUTICAL CO., LTD. Mosapride Product Portfolio Table 64. SAWAI PHARMACEUTICAL CO., LTD. Recent Development Table 65. Sumitomo Dainippon Pharma Company Information Table 66. Sumitomo Dainippon Pharma Business Overview Table 67. Sumitomo Dainippon Pharma Mosapride Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Sumitomo Dainippon Pharma Mosapride Product Portfolio Table 69. Sumitomo Dainippon Pharma Recent Development Table 70. Konghong Pharmaceutical Company Information Table 71. Konghong Pharmaceutical Business Overview Table 72. Konghong Pharmaceutical Mosapride Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Konghong Pharmaceutical Mosapride Product Portfolio Table 74. Konghong Pharmaceutical Recent Development Table 75. HAOSON PHARMA Company Information Table 76. HAOSON PHARMA Business Overview Table 77. HAOSON PHARMA Mosapride Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. HAOSON PHARMA Mosapride Product Portfolio Table 79. HAOSON PHARMA Recent Development Table 80. Lunan Pharmaceutical Group Company Information Table 81. Lunan Pharmaceutical Group Business Overview Table 82. Lunan Pharmaceutical Group Mosapride Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Lunan Pharmaceutical Group Mosapride Product Portfolio Table 84. Lunan Pharmaceutical Group Recent Development Table 85. Research Programs/Design for This Report Table 86. Authors List of This Report Table 87. Secondary Sources Table 88. Primary Sources List of Figures Figure 1. Mosapride Product Image Figure 2. Global Mosapride Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mosapride Market Size (2021-2032) & (US$ Million) Figure 4. Global Mosapride Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Tablet Image Figure 8. Capsule Image Figure 9. Others Image Figure 10. Global Mosapride Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Mosapride Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Mosapride Sales Value Share by Type (2021-2032) Figure 13. Gastritis Image Figure 14. Dyspepsia Image Figure 15. Others Image Figure 16. Global Mosapride Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Mosapride Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Mosapride Sales Value Share by Application (2021-2032) Figure 19. Global Mosapride Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Mosapride Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Mosapride Sales Value (2021-2032) & (US$ Million) Figure 22. North America Mosapride Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Mosapride Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Mosapride Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Mosapride Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Mosapride Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Mosapride Sales Value (2021-2032) & (US$ Million) Figure 28. South America Mosapride Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Mosapride Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Mosapride Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Mosapride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Mosapride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Mosapride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Mosapride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Mosapride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Mosapride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Mosapride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Mosapride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Mosapride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Mosapride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Mosapride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Mosapride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Mosapride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Mosapride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Mosapride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Mosapride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Mosapride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Mosapride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Mosapride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Mosapride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Mosapride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Mosapride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Mosapride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Mosapride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Mosapride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Mosapride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Mosapride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Mosapride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Mosapride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Mosapride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Mosapride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Mosapride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Mosapride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Mosapride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Mosapride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Mosapride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Mosapride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Mosapride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Mosapride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Mosapride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Mosapride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Mosapride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Mosapride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Mosapride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Mosapride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Mosapride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Mosapride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Mosapride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Mosapride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Mosapride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Mosapride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Mosapride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Mosapride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Mosapride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Mosapride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Mosapride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Mosapride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Mosapride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Mosapride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Mosapride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Mosapride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Mosapride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Mosapride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Mosapride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Mosapride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Mosapride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Mosapride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Mosapride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Mosapride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Mosapride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Mosapride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Mosapride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Mosapride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Mosapride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Mosapride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Mosapride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Mosapride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Mosapride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Mosapride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Mosapride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Mosapride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Mosapride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Mosapride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Mosapride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Capsule
  • Others
Applications
  • Gastritis
  • Dyspepsia
  • Others
Companies covered
  • DAIICHI SANKYO
  • Dainippon Pharmaceutical Co., Ltd.
  • Nihon Generic
  • NIPPON CHEMIPHAR CO., LTD.
  • SAWAI PHARMACEUTICAL CO., LTD.
  • Sumitomo Dainippon Pharma
  • Konghong Pharmaceutical
  • HAOSON PHARMA
  • Lunan Pharmaceutical Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Mosapride Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Mosapride Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Mosapride Market Dynamics
  1. 2.1 Mosapride Industry Trends
  2. 2.2 Mosapride Industry Drivers
  3. 2.3 Mosapride Industry Opportunities and Challenges
  4. 2.4 Mosapride Industry Restraints
3 Mosapride Market by Company
  1. 3.1 Global Mosapride Company Revenue Ranking in 2025
  2. 3.2 Global Mosapride Revenue by Company (2021-2026)
  3. 3.3 Global Mosapride Company Ranking (2024-2026)
  4. 3.4 Global Mosapride Company Manufacturing Base and Headquarters
  5. 3.5 Global Mosapride Company Product Type and Application
  6. 3.6 Global Mosapride Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Mosapride Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Mosapride Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Mosapride Market by Type
  1. 4.1 Mosapride Type Introduction
  2. 4.1.1 Tablet
  3. 4.1.2 Capsule
  4. 4.1.3 Others
  5. 4.2 Global Mosapride Sales Value by Type
  6. 4.2.1 Global Mosapride Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Mosapride Sales Value by Type (2021-2032)
  8. 4.2.3 Global Mosapride Sales Value Share by Type (2021-2032)
5 Mosapride Market by Application
  1. 5.1 Mosapride Application Introduction
  2. 5.1.1 Gastritis
  3. 5.1.2 Dyspepsia
  4. 5.1.3 Others
  5. 5.2 Global Mosapride Sales Value by Application
  6. 5.2.1 Global Mosapride Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Mosapride Sales Value by Application (2021-2032)
  8. 5.2.3 Global Mosapride Sales Value Share by Application (2021-2032)
6 Mosapride Regional Value Analysis
  1. 6.1 Global Mosapride Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mosapride Sales Value by Region (2021-2032)
  3. 6.2.1 Global Mosapride Sales Value by Region: 2021-2026
  4. 6.2.2 Global Mosapride Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Mosapride Sales Value (2021-2032)
  7. 6.3.2 North America Mosapride Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Mosapride Sales Value (2021-2032)
  10. 6.4.2 Europe Mosapride Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Mosapride Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Mosapride Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Mosapride Sales Value (2021-2032)
  16. 6.6.2 South America Mosapride Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Mosapride Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Mosapride Sales Value Share by Country, 2025 VS 2032
7 Mosapride Country-level Value Analysis
  1. 7.1 Global Mosapride Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Mosapride Sales Value by Country (2021-2032)
  3. 7.2.1 Global Mosapride Sales Value by Country (2021-2026)
  4. 7.2.2 Global Mosapride Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Mosapride Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Mosapride Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Mosapride Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Mosapride Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Mosapride Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Mosapride Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Mosapride Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Mosapride Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Mosapride Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Mosapride Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Mosapride Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Mosapride Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Mosapride Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Mosapride Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Mosapride Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Mosapride Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Mosapride Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Mosapride Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Mosapride Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Mosapride Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Mosapride Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Mosapride Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Mosapride Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Mosapride Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Mosapride Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Mosapride Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Mosapride Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Mosapride Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Mosapride Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Mosapride Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Mosapride Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Mosapride Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Mosapride Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Mosapride Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Mosapride Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Mosapride Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Mosapride Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Mosapride Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Mosapride Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Mosapride Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Mosapride Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Mosapride Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Mosapride Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Mosapride Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Mosapride Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Mosapride Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Mosapride Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Mosapride Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Mosapride Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Mosapride Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Mosapride Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Mosapride Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Mosapride Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Mosapride Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Mosapride Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Mosapride Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Mosapride Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Mosapride Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Mosapride Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Mosapride Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Mosapride Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Mosapride Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Mosapride Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Mosapride Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Mosapride Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Mosapride Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Mosapride Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Mosapride Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Mosapride Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Mosapride Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Mosapride Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Mosapride Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Mosapride Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Mosapride Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Mosapride Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Mosapride Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Mosapride Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Mosapride Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Mosapride Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Mosapride Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Mosapride Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Mosapride Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Mosapride Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Mosapride Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 DAIICHI SANKYO
  2. 8.1.1 DAIICHI SANKYO Company Information
  3. 8.1.2 DAIICHI SANKYO Business Overview
  4. 8.1.3 DAIICHI SANKYO Mosapride Revenue and Gross Margin (2021-2026)
  5. 8.1.4 DAIICHI SANKYO Mosapride Product Portfolio
  6. 8.1.5 DAIICHI SANKYO Recent Developments
  7. 8.2 Dainippon Pharmaceutical Co., Ltd.
  8. 8.2.1 Dainippon Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Dainippon Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Dainippon Pharmaceutical Co., Ltd. Mosapride Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Dainippon Pharmaceutical Co., Ltd. Mosapride Product Portfolio
  12. 8.2.5 Dainippon Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Nihon Generic
  14. 8.3.1 Nihon Generic Company Information
  15. 8.3.2 Nihon Generic Business Overview
  16. 8.3.3 Nihon Generic Mosapride Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Nihon Generic Mosapride Product Portfolio
  18. 8.3.5 Nihon Generic Recent Developments
  19. 8.4 NIPPON CHEMIPHAR CO., LTD.
  20. 8.4.1 NIPPON CHEMIPHAR CO., LTD. Company Information
  21. 8.4.2 NIPPON CHEMIPHAR CO., LTD. Business Overview
  22. 8.4.3 NIPPON CHEMIPHAR CO., LTD. Mosapride Revenue and Gross Margin (2021-2026)
  23. 8.4.4 NIPPON CHEMIPHAR CO., LTD. Mosapride Product Portfolio
  24. 8.4.5 NIPPON CHEMIPHAR CO., LTD. Recent Developments
  25. 8.5 SAWAI PHARMACEUTICAL CO., LTD.
  26. 8.5.1 SAWAI PHARMACEUTICAL CO., LTD. Company Information
  27. 8.5.2 SAWAI PHARMACEUTICAL CO., LTD. Business Overview
  28. 8.5.3 SAWAI PHARMACEUTICAL CO., LTD. Mosapride Revenue and Gross Margin (2021-2026)
  29. 8.5.4 SAWAI PHARMACEUTICAL CO., LTD. Mosapride Product Portfolio
  30. 8.5.5 SAWAI PHARMACEUTICAL CO., LTD. Recent Developments
  31. 8.6 Sumitomo Dainippon Pharma
  32. 8.6.1 Sumitomo Dainippon Pharma Company Information
  33. 8.6.2 Sumitomo Dainippon Pharma Business Overview
  34. 8.6.3 Sumitomo Dainippon Pharma Mosapride Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sumitomo Dainippon Pharma Mosapride Product Portfolio
  36. 8.6.5 Sumitomo Dainippon Pharma Recent Developments
  37. 8.7 Konghong Pharmaceutical
  38. 8.7.1 Konghong Pharmaceutical Company Information
  39. 8.7.2 Konghong Pharmaceutical Business Overview
  40. 8.7.3 Konghong Pharmaceutical Mosapride Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Konghong Pharmaceutical Mosapride Product Portfolio
  42. 8.7.5 Konghong Pharmaceutical Recent Developments
  43. 8.8 HAOSON PHARMA
  44. 8.8.1 HAOSON PHARMA Company Information
  45. 8.8.2 HAOSON PHARMA Business Overview
  46. 8.8.3 HAOSON PHARMA Mosapride Revenue and Gross Margin (2021-2026)
  47. 8.8.4 HAOSON PHARMA Mosapride Product Portfolio
  48. 8.8.5 HAOSON PHARMA Recent Developments
  49. 8.9 Lunan Pharmaceutical Group
  50. 8.9.1 Lunan Pharmaceutical Group Company Information
  51. 8.9.2 Lunan Pharmaceutical Group Business Overview
  52. 8.9.3 Lunan Pharmaceutical Group Mosapride Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Lunan Pharmaceutical Group Mosapride Product Portfolio
  54. 8.9.5 Lunan Pharmaceutical Group Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst